OncoGEMINI: software for investigating tumor variants from multiple biopsies with integrated cancer annotations

[1]  Alzheimer's Disease Neuroimaging Initiative,et al.  Non-Coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases , 2019, bioRxiv.

[2]  D. Nickerson,et al.  Exome sequencing of family trios from the National Birth Defects Prevention Study: Tapping into a rich resource of genetic and environmental data. , 2019, Birth defects research.

[3]  A. Nordgren,et al.  Early activating somatic PIK3CA mutations promote ectopic muscle development and upper limb overgrowth , 2019, Clinical genetics.

[4]  Christopher T. Saunders,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[5]  Alex H. Wagner,et al.  DGIdb 3.0: a redesign and expansion of the drug–gene interaction database , 2017, bioRxiv.

[6]  Brent S. Pedersen,et al.  Combating subclonal evolution of resistant cancer phenotypes , 2017, Nature Communications.

[7]  Michael P. Schroeder,et al.  Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations , 2017, Genome Medicine.

[8]  Moriah H Nissan,et al.  OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.

[9]  Eivind Hovig,et al.  Personal Cancer Genome Reporter: variant interpretation report for precision oncology , 2017, bioRxiv.

[10]  Steven J. M. Jones,et al.  CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer , 2017, Nature Genetics.

[11]  Hannah Carter,et al.  CRAVAT: cancer-related analysis of variants toolkit , 2013, Bioinform..

[12]  Stephen Fox,et al.  The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE” , 2016, PLoS medicine.

[13]  Joshua F. McMichael,et al.  DoCM: a database of curated mutations in cancer , 2016, Nature Methods.

[14]  V. Seshan,et al.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing , 2016, Nucleic acids research.

[15]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[16]  Brent S. Pedersen,et al.  Vcfanno: fast, flexible annotation of genetic variants , 2016, Genome Biology.

[17]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[18]  Mel Greaves,et al.  Evolutionary determinants of cancer. , 2015, Cancer discovery.

[19]  T. Schumacher,et al.  Neoantigens in cancer immunotherapy , 2015, Science.

[20]  Trevor J Pugh,et al.  Oncotator: Cancer Variant Annotation Tool , 2015, Human mutation.

[21]  Steven J. M. Jones,et al.  Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma , 2014, Science.

[22]  Aaron R. Quinlan,et al.  GEMINI: Integrative Exploration of Genetic Variation and Genome Annotations , 2013, PLoS Comput. Biol..

[23]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[24]  Gabor T. Marth,et al.  Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.

[25]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[26]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[27]  C. Cole,et al.  COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.

[28]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[29]  Shicai Wang,et al.  COSMIC: the Catalogue Of Somatic Mutations In Cancer , 2018, Nucleic Acids Res..

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  J. Huxley.  Biological aspects of cancer , 1959 .

[32]  Th. Boveri,et al.  The origin of malignant tumors , 1929 .